Cas 25862-30-0,<i>N</i>-[4-(3-cyclohexyl-2-imino-imidazolidine-1-sulfonyl)-phenethyl]-2-methoxy-benzamide

25862-30-0

Post Buying Request

Basic information

Product Name: N-[4-(3-cyclohexyl-2-imino-imidazolidine-1-sulfonyl)-phenethyl]-2-methoxy-benzamide
Synonyms: N-[4-(3-cyclohexyl-2-imino-imidazolidine-1-sulfonyl)-phenethyl]-2-methoxy-benzamide
CAS NO:25862-30-0
Molecular Formula:
Molecular Weight: 484.619
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-[4-(3-cyclohexyl-2-imino-imidazolidine-1-sulfonyl)-phenethyl]-2-methoxy-benzamide(CAS DataBase Reference)
NIST Chemistry Reference: N-[4-(3-cyclohexyl-2-imino-imidazolidine-1-sulfonyl)-phenethyl]-2-methoxy-benzamide(25862-30-0)
EPA Substance Registry System: N-[4-(3-cyclohexyl-2-imino-imidazolidine-1-sulfonyl)-phenethyl]-2-methoxy-benzamide(25862-30-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 25862-30-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

25862-30-0 Suppliers

Recommended suppliers

25862-30-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 25862-30-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,8,6 and 2 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 25862-30:
(7*2)+(6*5)+(5*8)+(4*6)+(3*2)+(2*3)+(1*0)=120
120 % 10 = 0
So 25862-30-0 is a valid CAS Registry Number.

25862-30-0Upstream product

25862-30-0Downstream Products

25862-30-0Relevant academic research and scientific papers

Sulfonyliminoimidazolidines. A new class of oral hypoglycemic agents. I. 1-[[p-[2-(Acylamino)ethyl]phenyl]sulfonyl]-2-iminoimidazolidines

Schweizer,Marki,Lehmann,Dietrich

, p. 964 - 970 (2007/10/02)

A series of 1-[[p-[2-(acylamino)ethyl]phenyl]sulfonyl]-2-iminoimidazolidines has been synthesized. Compounds from this new class of oral hypoglycemic agents lower blood glucose in normal and in streptozotocin-diabetic rats. Potent analogues were obtained

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 25862-30-0